Myocardial perfusion imaging with regadenoson stress in advanced lung disease

J Nucl Cardiol. 2020 Jun;27(3):912-914. doi: 10.1007/s12350-019-01904-8. Epub 2019 Oct 3.

Authors

Jussi Schultz¹, Antti Saraste^{2

3}

Affiliations

¹ Turku PET Centre, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, 20520, Turku, Finland.
² Turku PET Centre, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, 20520, Turku, Finland. antti.saraste@utu.fi.
³ Heart Center, Turku University Hospital, Hämeentie 11, 20520, Turku, Finland. antti.saraste@utu.fi.

PMID: 31583524
DOI: 10.1007/s12350-019-01904-8

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Feasibility Studies
Humans
Lung Diseases*
Myocardial Perfusion Imaging*
Purines
Pyrazoles
Tomography, Emission-Computed, Single-Photon

Substances

Purines
Pyrazoles
regadenoson